Category: Publications
Search News
‘Sugar-coated’ tumour matrix may offer way to make triple-negative breast cancer easier to treat
16th June 2026
Researchers have discovered a way in which the environment surrounding triple-negative breast cancer cells helps suppress our immune system, making this cancer harder to treat. The findings open the door to a potential new treatment strategy that could make triple-negative breast cancers more vulnerable to the immune system and help more people to benefit from immunotherapy in future.
Read more
Study offers clues to blood cancer risk, revealing how gene mutations compete over time
5th May 2026
Researchers have developed a new way to understand how genetic changes linked to blood cancer evolve in our cells, offering new insight into predicting blood cancer risk.
Read more
New £1m clinical trial launches to improve quality of life for people with blood cancer
8th April 2026
Dr Kevin Rouault-Pierre and team at Barts Cancer Institute, Queen Mary University of London, have been awarded funding to launch a new clinical trial aiming to improve quality of life for people living with a form of blood cancer called myelodysplastic syndromes, which currently has limited treatment options.
Read more
Lab-grown ovarian ‘mini-tumours’ provide new tool for immunotherapy research
25th March 2026
Researchers have developed a way to grow miniature ovarian tumours in the lab that mimic the tumour environment found in patients. The new approach offers a useful way to study how cancer cells interact with the immune system and to explore potential treatments. Ultimately, it could help accelerate progress for patients and reduce reliance on research methods involving animals.
Read more
New approach offers hope for people with rare eye cancer
21st January 2026
A more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer, according to researchers at Barts Cancer Institute, Queen Mary University of London. The findings, from a retrospective study of the largest UK cohort of patients with this condition to date, offer an encouraging sign of progress in this rare and difficult-to-treat cancer.
Read more
Discovery reveals new understanding of cancer-driving proteins in rare brain tumours and beyond
7th November 2025
Scientists have discovered that a single letter change in a gene called PRKCA drives a rare and hard-to-treat brain cancer, chordoid glioma, through an entirely unexpected mechanism. The findings could open up new ways to design targeted treatments for this difficult-to-treat disease, and possibly for other cancers involving the same gene.
Read more